HAPPEportfolio

HAPPE Spine and cultivate(MD)

HAPPE Spine Announces Andrew Iott as President and CEO

Grand Rapids, Mich., December 7, 2022 — HAPPE Spine announces that Andrew Iott has accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience in medical device product development and commercialization, with extensive knowledge of the spine market. As a co-founder of Globus Medical, Mr. Iott played a […]

HAPPE Spine Announces Andrew Iott as President and CEO Read More »

HAPPE Spine and cultivate(MD)

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices

Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announces today that one of their portfolio companies, Grand Rapids, MI based HAPPE Spine was granted two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices Read More »